Back
ESC Premium Access

Results from the CAMI1 Study: Selective CRP apheresis as a new treatment option in acute myocardial infarction

Session: Non-troponin biomarkers in acute coronary syndromes
Topic: ST-Elevation Myocardial Infarction (STEMI)
Speaker: Professor C. Garlichs (Flensburg, DE)
Event: ESC Congress 2019

Congress Presentation

Add to my library

Like

About the speaker

Professor Christoph Dietrich Garlichs

Deaconess Hospital Flensburg, Flensburg (Germany)
0 follower

4 more presentations in this session

Circulating serum extracellular matrix degradation enzyme cathepsin S predicts mortality and improves risk stratification over the GRACE score in patients with non-ST elevation acute coronary syndrom

Speaker: Doctor K. Sopova (Mannheim, DE)

Access
Abstract
Like
Thumbnail

Apoptotic and non-apoptotic circulating microparticles in patients with acute coronary syndromes

Speaker: Doctor A. Antonopoulos (Athens, GR)

Access
Abstract
Like
Thumbnail

HsCRP predicts mortality beyond troponin in 102,337 patients with suspected acute coronary syndrome (CRP-RISK study)

Speaker: Doctor A. Kaura (London, GB)

Access
Abstract
Slides
Video
Like
Thumbnail

Circulating levels of ST2 are associated with myocardial injury, left ventricular function and future adverse clinical events in patients with ST-elevation myocardial infarction.

Speaker: Doctor J. Eritsland (Oslo, NO)

Access
Abstract
Slides
Video
Like
Thumbnail

Access the full session

Non-troponin biomarkers in acute coronary syndromes

Speakers: Professor C. Garlichs, Doctor K. Sopova, Doctor A. Antonopoulos, Doctor A. Kaura, Doctor J. Eritsland
Access
Like
Thumbnail

About the event

Image

ESC Congress 2019

31 August - 4 September 2019

Sessions Presentations

Congress
logo Image

ESC 365 is supported by

logo Bristol Myers Squibb Explore sponsored resources
logo Novo Nordisk Explore sponsored resources